Amit Gupta - 01 Apr 2026 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CDLX
Reported as of: 01 Apr 2026
Net transaction value: -$118,426
SEC form: 4
Accepted by SEC: 02 Apr 2026, 18:19:46 UTC
Prior SEC filing: 03 Mar 2026
Next SEC filing: 06 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Nick Lynton, Attorney-in-Fact

Key filing fact

Amit Gupta filed Form 4 for Cardlytics, Inc. (CDLX) on 02 Apr 2026.

Key facts

This page summarizes Amit Gupta's Form 4 filing for Cardlytics, Inc. (CDLX).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 02 Apr 2026, 18:19.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: -$118,426.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001961238 Primary reporting owner

Gupta Amit

Relationship: Chief Executive Officer, Director
Address: 675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA
Signature: /s/ Nick Lynton, Attorney-in-Fact
Signature date: 02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDLX transaction

Common Stock

Options Exercise

Transaction value
Shares: +14,350
Change %: +2.2%
Price
Shares after: 673,994
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1

CDLX transaction

Common Stock

Options Exercise

Transaction value
Shares: +500,000
Change %: +74%
Price
Shares after: 1,173,994
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1

CDLX transaction

Common Stock

Sale

Transaction value: $61,924
Shares: -62,549
Change %: -5.3%
Price: $0.9900
Shares after: 1,111,445
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F2, F3

CDLX transaction

Common Stock

Sale

Transaction value: $56,502
Shares: -54,225
Change %: -4.9%
Price: $1.04
Shares after: 1,057,220
Date: 02 Apr 2026
Ownership: Direct
Footnotes: F2, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDLX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -14,350
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,350
Exercise price
Footnotes: F1, F5

CDLX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -500,000
Change %: -50%
Price: $0.000000^*
Shares after: 500,000
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

Footnote F2

Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2026. The Reporting Person did not sell shares for any other purpose.

Footnote F3

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $0.965 to $1.040, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4) in this Form 4.

Footnote F4

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $0.972 to $1.085, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4) in this Form 4.

Footnote F5

The RSU award was originally for 114,796 shares. The RSU award vested in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026.

Footnote F6

50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.